Hy – Orris AI

Hey there! How can I help you today?

Test me in these topics in form of mcqs Anterior pituitary and posterior pituitary Siadh,adh,prolactin,prolactinoma,gh,acromegaly and gigantism hh axis,oxytocin and diabetes insipidus

Asking for Preferences

Here are your 25 Mixed-Level MCQs covering all the topics you listed. Answer them all, then let me know when you're ready for the answer key!

🧠 Pituitary & Related Hormones - MCQ Test

Q1. Which of the following hormones is NOT secreted by the anterior pituitary?

A) TSH
B) ADH
C) ACTH
D) FSH

Q2. The anterior pituitary is derived embryologically from:

A) Neuroectoderm
B) Neural crest cells
C) Rathke's pouch
D) Infundibulum

Q3. ADH (vasopressin) acts primarily on which part of the nephron?

A) Proximal convoluted tubule
B) Loop of Henle (ascending limb)
C) Collecting duct
D) Distal convoluted tubule (early)

Q4. A 45-year-old man with small cell lung cancer develops hyponatremia (Na+ 118 mEq/L), concentrated urine, and euvolemia. What is the most likely diagnosis?

A) Diabetes insipidus
B) Addison's disease
C) SIADH
D) Psychogenic polydipsia

Q5. The FIRST-LINE treatment for SIADH is:

A) Hypertonic saline (3%)
B) Fluid restriction
C) Demeclocycline
D) Tolvaptan

Q6. Which of the following is NOT a cause of SIADH?

A) Carbamazepine
B) Lithium
C) Pulmonary tuberculosis
D) Meningitis

Q7. Diabetes insipidus is characterized by:

A) High urine osmolality, low serum osmolality
B) Low urine osmolality, high serum osmolality
C) Low urine osmolality, low serum osmolality
D) High urine osmolality, high serum osmolality

Q8. Central diabetes insipidus is distinguished from nephrogenic DI by:

A) Water deprivation test alone
B) Response to exogenous desmopressin (DDAVP)
C) Serum ADH levels
D) Urine sodium concentration

Q9. Which drug is used to treat nephrogenic diabetes insipidus?

A) Desmopressin
B) Carbamazepine
C) Thiazide diuretics
D) Loop diuretics

Q10. Prolactin secretion is under predominant inhibitory control by:

A) TRH
B) Dopamine
C) Estrogen
D) VIP (Vasoactive intestinal peptide)

Q11. A 28-year-old woman presents with amenorrhea, galactorrhea, and infertility. MRI shows a 5 mm pituitary lesion. What is the most appropriate first-line treatment?

A) Transsphenoidal surgery
B) Bromocriptine or cabergoline
C) Radiation therapy
D) Estrogen replacement

Q12. Prolactinoma is classified as a macroadenoma when its size is:

A) > 5 mm
B) > 8 mm
C) > 10 mm
D) > 15 mm

Q13. Which of the following is TRUE about Growth Hormone (GH)?

A) It is secreted in a continuous, pulsatile-free manner
B) Its secretion is stimulated by somatostatin
C) It promotes lipolysis and gluconeogenesis
D) It directly stimulates bone growth without IGF-1

Q14. IGF-1 (Insulin-like Growth Factor 1) is primarily produced by the:

A) Pancreas
B) Kidneys
C) Liver
D) Hypothalamus

Q15. A 40-year-old man presents with enlarged hands and feet, prognathism, increased hat size, and hypertension. His fasting GH level is 25 ng/mL. The BEST confirmatory test is:

A) Random GH level
B) IGF-1 level + GH suppression after oral glucose load
C) MRI pituitary without confirmation
D) 24-hour urinary GH

Q16. Which of the following is a complication of acromegaly?

A) Hyposomnia only
B) Carpal tunnel syndrome
C) Hypoglycemia
D) Pituitary hypofunction is never seen

Q17. Gigantism differs from acromegaly in that it occurs:

A) Due to excess cortisol
B) Before closure of the epiphyseal plates
C) Only in females
D) Due to excess prolactin

Q18. The hypothalamic hormone that stimulates GH secretion is:

A) Somatostatin
B) Dopamine
C) GHRH (Growth Hormone Releasing Hormone)
D) CRH

Q19. Regarding the HH (Hypothalamo-Hypophyseal) axis, which statement is CORRECT?

A) The posterior pituitary synthesizes ADH and oxytocin
B) Hypothalamic hormones reach the anterior pituitary via direct nerve fibers
C) ADH and oxytocin are synthesized in the anterior pituitary
D) The posterior pituitary communicates via the hypothalamo-hypophyseal portal system

Q20. ADH and oxytocin are synthesized in the hypothalamus by:

A) Arcuate nucleus and ventromedial nucleus
B) Supraoptic and paraventricular nuclei
C) Preoptic nucleus only
D) Median eminence

Q21. Oxytocin's primary physiological roles include:

A) Uterine contraction during labor and milk ejection reflex
B) Water retention and vasoconstriction
C) Stimulation of GH release
D) Inhibition of prolactin secretion

Q22. Which of the following BEST describes the "Ferguson reflex"?

A) GH feedback on the hypothalamus
B) Positive feedback of oxytocin release during labor due to cervical stretching
C) Milk ejection in response to suckling
D) ADH release in response to pain

Q23. A patient post-pituitary surgery develops polyuria (8 L/day), polydipsia, and urine specific gravity of 1.001. Serum Na+ is 152 mEq/L. What is the diagnosis?

A) SIADH
B) Central diabetes insipidus
C) Primary polydipsia
D) Type 2 diabetes mellitus

Q24. Which MEN (Multiple Endocrine Neoplasia) syndrome is prolactinoma most classically associated with?

A) MEN 1
B) MEN 2A
C) MEN 2B
D) MEN 4

Q25. A drug that blocks dopamine receptors (e.g., metoclopramide, antipsychotics) would be expected to:

A) Decrease prolactin levels
B) Increase prolactin levels
C) Have no effect on prolactin
D) Increase GH levels

Take your time and answer all 25! When you're done, type "Show answers" and I'll give you the full answer key with explanations. 💪

Show answers

Here is the full answer key with explanations:

✅ Answer Key with Explanations

Q1. Answer: B) ADH ADH (antidiuretic hormone) is secreted by the posterior pituitary (actually synthesized in the hypothalamus and stored/released from the posterior pituitary). The anterior pituitary secretes TSH, ACTH, FSH, LH, GH, and Prolactin - remember: FLATPIG (FSH, LH, ACTH, TSH, Prolactin, IGF, GH).

Q2. Answer: C) Rathke's pouch The anterior pituitary (adenohypophysis) develops from Rathke's pouch, an upward evagination of the oral ectoderm. The posterior pituitary (neurohypophysis) develops from neuroectoderm as a downward extension of the brain.

Q3. Answer: C) Collecting duct ADH acts on V2 receptors in the collecting duct (and to a lesser extent, the late distal tubule), inserting aquaporin-2 channels to increase water reabsorption. At high concentrations, it also acts on V1 receptors to cause vasoconstriction.

Q4. Answer: C) SIADH Classic SIADH triad: hyponatremia + concentrated urine (urine osm > serum osm) + euvolemia. Small cell lung cancer is the most common cause of ectopic ADH production. Key: urine Na+ > 20 mEq/L despite hyponatremia.

Q5. Answer: B) Fluid restriction Fluid restriction (500-1000 mL/day) is the first-line treatment for SIADH. Hypertonic saline is reserved for severe symptomatic hyponatremia (seizures, coma). Tolvaptan (V2 receptor antagonist) and demeclocycline are used in chronic refractory cases.

Q6. Answer: B) Lithium Lithium causes nephrogenic diabetes insipidus (interferes with ADH action in the collecting duct), NOT SIADH. All others cause SIADH: carbamazepine (stimulates ADH release), pulmonary TB, meningitis (CNS causes increase ADH).

Q7. Answer: B) Low urine osmolality, high serum osmolality In DI, there is inability to concentrate urine despite high serum osmolality. Result: dilute urine (low urine osm < 300 mOsm/kg, specific gravity < 1.005) with high serum osmolality and hypernatremia.

Q8. Answer: B) Response to exogenous desmopressin (DDAVP) After water deprivation confirms DI (failure to concentrate urine), DDAVP is given:

Central DI: urine osmolality rises > 50% (kidneys respond normally to exogenous ADH)
Nephrogenic DI: little/no response (kidneys are resistant to ADH)

Q9. Answer: C) Thiazide diuretics Paradoxically, thiazide diuretics treat nephrogenic DI by causing mild volume depletion, increasing proximal tubule reabsorption, and reducing urine output. NSAIDs and low-salt/low-protein diet also help. Desmopressin works only in central DI.

Q10. Answer: B) Dopamine Prolactin is unique - it is under predominant inhibitory control by dopamine (from the hypothalamus). Dopamine = "prolactin inhibiting factor (PIF)." TRH and VIP stimulate prolactin. Estrogen also stimulates it (explains elevated prolactin in pregnancy).

Q11. Answer: B) Bromocriptine or cabergoline A 5 mm lesion = microadenoma. First-line for prolactinoma (both micro and macro) is dopamine agonists (cabergoline preferred due to fewer side effects). Surgery is reserved for drug resistance/intolerance or optic chiasm compression unresponsive to therapy.

Q12. Answer: C) > 10 mm

Microadenoma: < 10 mm
Macroadenoma: > 10 mm Macroadenomas can compress the optic chiasm (bitemporal hemianopia) and cause hypopituitarism by compression of normal pituitary tissue.

Q13. Answer: C) It promotes lipolysis and gluconeogenesis GH is a counter-regulatory hormone - it promotes lipolysis (breaks down fat for energy) and gluconeogenesis (raises blood glucose - "diabetogenic" effect). GH secretion is inhibited by somatostatin. GH acts indirectly via IGF-1 for most anabolic effects. GH is secreted in pulsatile fashion (peaks at night during slow-wave sleep).

Q14. Answer: C) Liver IGF-1 (somatomedin C) is primarily produced by the liver in response to GH stimulation. It mediates most of GH's growth-promoting effects, particularly on bone (linear growth). IGF-1 levels are used as a screening test for GH excess/deficiency.

Q15. Answer: B) IGF-1 level + GH suppression after oral glucose load The gold standard for confirming acromegaly is the oral glucose tolerance test (OGTT): in normal individuals, GH is suppressed to < 1 ng/mL after a 75g glucose load. In acromegaly, GH fails to suppress (may even paradoxically rise). IGF-1 is an excellent screening test.

Q16. Answer: B) Carpal tunnel syndrome Acromegaly complications include: carpal tunnel syndrome (soft tissue/nerve overgrowth), sleep apnea, hypertension, diabetes mellitus, cardiomegaly, arthropathy, colonic polyps, and hypopituitarism from tumor mass effect. NOT hypoglycemia (GH is diabetogenic).

Q17. Answer: B) Before closure of the epiphyseal plates Gigantism = GH excess in children/adolescents before epiphyseal fusion → proportional tall stature with elongated long bones. Acromegaly = GH excess in adults after epiphyseal fusion → bones widen/thicken (acral enlargement) rather than lengthen.

Q18. Answer: C) GHRH (Growth Hormone Releasing Hormone) The hypothalamic axis for GH: GHRH (stimulates GH release) vs. Somatostatin (inhibits GH release). Ghrelin (from stomach) also stimulates GH. GH then stimulates IGF-1 from liver, and IGF-1 feeds back to inhibit both GH and GHRH.

Q19. Answer: A) The posterior pituitary synthesizes ADH and oxytocin This is a common trick - ADH and oxytocin are synthesized in the hypothalamus (supraoptic and paraventricular nuclei) but stored and released from the posterior pituitary. The anterior pituitary communicates via the portal system. The posterior pituitary communicates via direct nerve axons (hypothalamo-hypophyseal tract).

Q20. Answer: B) Supraoptic and paraventricular nuclei

Supraoptic nucleus - mainly ADH synthesis
Paraventricular nucleus - mainly oxytocin synthesis (also some ADH) Both travel down axons through the pituitary stalk to be stored in the posterior pituitary (pars nervosa).

Q21. Answer: A) Uterine contraction during labor and milk ejection reflex Oxytocin's two main roles:

Myometrial contraction during labor (used clinically as Pitocin/syntocinon)
Milk ejection (let-down reflex) in response to suckling It also has social bonding/trust roles in the brain. It does NOT cause milk production (that's prolactin).

Q22. Answer: B) Positive feedback of oxytocin release during labor due to cervical stretching The Ferguson reflex is a classic positive feedback loop: cervical stretching → afferent signals to hypothalamus → more oxytocin released → stronger uterine contractions → more cervical stretching → more oxytocin... This continues until delivery.

Q23. Answer: B) Central diabetes insipidus Post-pituitary surgery disrupting the stalk = loss of ADH release = central DI. Features: massive polyuria, dilute urine (SG 1.001, osm < 200), hypernatremia, polydipsia. Treated with desmopressin (DDAVP).

Q24. Answer: A) MEN 1 MEN 1 (Wermer syndrome) = "3 P's": Pituitary adenoma (prolactinoma most common) + Parathyroid hyperplasia + Pancreatic tumors (gastrinoma most common). Gene: MEN1 (menin). MEN 2A/2B involve medullary thyroid cancer + pheochromocytoma.

Q25. Answer: B) Increase prolactin levels Dopamine normally inhibits prolactin release. Blocking dopamine receptors (metoclopramide, haloperidol, risperidone, domperidone) removes this inhibition → elevated prolactin → galactorrhea, amenorrhea, gynecomastia. This is a classic drug-induced hyperprolactinemia mechanism.

📊 Score Yourself

Score	Grade
23-25	🏆 Excellent - Exam Ready!
19-22	👍 Good - Minor review needed
15-18	📖 Fair - Revisit weak areas
< 15	🔄 Needs more study

How did you score? Let me know if you want deeper explanations on any topic or another round of MCQs! 💪

Test me in these topics in form of mcqs Anterior pituitary and posterior pituitary Siadh,adh,prolactin,prolactinoma,gh,acromegaly and gigantism hh axis,oxytocin and diabetes insipidus make again ,like I can mark correct answer here

Here are 25 fresh MCQs — select your answer for each one, then tell me your choices and I'll score and explain them!

🧠 Pituitary & Related Hormones — MCQ Test (Round 2)

Q1. Which anterior pituitary hormone directly stimulates cortisol secretion from the adrenal cortex?

A) TSH
B) FSH
C) ACTH
D) GH

Q2. The portal blood supply to the anterior pituitary originates from which structure?

A) Circle of Willis
B) Median eminence of the hypothalamus
C) Posterior communicating artery
D) Cavernous sinus

Q3. Which of the following best describes the "stalk effect" in a pituitary macroadenoma?

A) Excess GH due to tumor secretion
B) Elevated prolactin due to interrupted dopamine delivery
C) Decreased TSH due to thyrotroph compression
D) Elevated ACTH due to portal disruption

Q4. ADH is primarily released in response to:

A) Decreased serum osmolality
B) Increased serum osmolality and decreased blood volume
C) Increased blood pressure
D) Hyperkalemia

Q5. Urine osmolality in a patient with SIADH is typically:

A) < 100 mOsm/kg
B) 100-200 mOsm/kg
C) > 300 mOsm/kg (inappropriately concentrated)
D) Equal to plasma osmolality

Q6. Which of the following lab findings is MOST consistent with SIADH?

A) Serum Na+ 148, urine Na+ 8, urine osm 80
B) Serum Na+ 118, urine Na+ 45, urine osm 520
C) Serum Na+ 118, urine Na+ 5, urine osm 90
D) Serum Na+ 148, urine Na+ 50, urine osm 600

Q7. Rapid correction of severe hyponatremia in SIADH can cause:

A) Cerebral edema
B) Osmotic demyelination syndrome (central pontine myelinolysis)
C) Hyperkalemia
D) Acute tubular necrosis

Q8. Which of the following is the MOST common cause of central diabetes insipidus?

A) Lithium toxicity
B) Idiopathic / autoimmune destruction of ADH-secreting neurons
C) Polycystic kidney disease
D) Hypocalcemia

Q9. In the water deprivation test, a patient fails to concentrate urine but responds to DDAVP with a > 50% rise in urine osmolality. This indicates:

A) Nephrogenic DI
B) Primary polydipsia
C) Central DI
D) SIADH

Q10. A woman stops breastfeeding but continues to produce milk 6 months later. Her serum prolactin is 180 ng/mL (normal < 25). The NEXT best investigation is:

A) Thyroid function tests
B) MRI of the pituitary
C) Serum estrogen levels
D) 24-hour urine cortisol

Q11. Which dopamine agonist is PREFERRED for prolactinoma due to better tolerability and efficacy?

A) Bromocriptine
B) Cabergoline
C) Pergolide
D) Apomorphine

Q12. Prolactin inhibits fertility primarily by:

A) Suppressing FSH/LH via inhibition of GnRH pulsatility
B) Directly blocking estrogen receptors
C) Stimulating somatostatin release
D) Inhibiting oxytocin release

Q13. Which of the following conditions paradoxically INCREASES GH secretion?

A) Obesity
B) Hyperglycemia
C) Type 1 diabetes mellitus (uncontrolled)
D) Hyperthyroidism

Q14. A patient with acromegaly most likely has a pituitary tumor arising from which cell type?

A) Corticotrophs
B) Somatotrophs
C) Lactotrophs
D) Thyrotrophs

Q15. Which cardiac complication is the leading cause of death in acromegaly?

A) Mitral valve prolapse
B) Acromegalic cardiomyopathy (biventricular hypertrophy)
C) Pericarditis
D) Atrial fibrillation alone

Q16. First-line MEDICAL treatment for acromegaly when surgery is not feasible is:

A) Dopamine agonists
B) Somatostatin analogues (octreotide, lanreotide)
C) GH receptor antagonist (pegvisomant)
D) Radiotherapy

Q17. A 10-year-old boy is noted to be in the 99th percentile for height with accelerating growth velocity. He has coarse facial features and enlarged hands. His IGF-1 is markedly elevated. The diagnosis is:

A) Acromegaly
B) Constitutional tall stature
C) Gigantism
D) Marfan syndrome

Q18. Which of the following is TRUE regarding somatostatin?

A) It stimulates GH release
B) It is secreted by the hypothalamus and also by D-cells of the pancreas
C) It increases glucagon secretion
D) It is identical in structure to GHRH

Q19. Oxytocin release is stimulated by all of the following EXCEPT:

A) Cervical dilation
B) Nipple stimulation/suckling
C) High serum osmolality
D) Estrogen (enhances sensitivity)

Q20. Which nucleus in the hypothalamus is MOST associated with oxytocin production?

A) Suprachiasmatic nucleus
B) Ventromedial nucleus
C) Paraventricular nucleus
D) Arcuate nucleus

Q21. The hypothalamo-hypophyseal portal system carries releasing hormones to the:

A) Posterior pituitary
B) Anterior pituitary
C) Pineal gland
D) Median eminence

Q22. Which of the following releasing hormones from the hypothalamus stimulates BOTH TSH and prolactin from the anterior pituitary?

A) GHRH
B) CRH
C) TRH
D) GnRH

Q23. Desmopressin (DDAVP) is a synthetic analogue of ADH that preferentially acts on:

A) V1 receptors (vascular)
B) V2 receptors (renal)
C) V3 receptors (pituitary)
D) Oxytocin receptors

Q24. A patient with nephrogenic DI would have which of the following ADH levels?

A) Low ADH
B) Normal ADH
C) High ADH (appropriate response to hypertonicity, but kidneys don't respond)
D) ADH is undetectable

Q25. MEN 1 syndrome includes a pituitary adenoma along with tumors of which other two organs?

A) Thyroid and adrenal medulla
B) Parathyroid and pancreas
C) Adrenal cortex and thyroid
D) Ovary and thyroid

📝 How to submit: Just reply with your 25 answers like: 1-C, 2-B, 3-A... and I'll instantly score you, tell you what you got right/wrong, and explain every answer! 🎯

1-c 2-B 4-B 5-c 6-A 7- 8-B 9 - A 10B 11 A 12-C 13-B 14-B 15-B 16-B 17-c 18-A 19–b 20-c 21-a 22-c 23-b 24-b 25-c

Here's your full scorecard! (Q3 and Q7 were skipped, so scored out of 23.)

📊 Your Results

Q	Your Answer	Correct	Result
1	C	C	✅
2	B	B	✅
3	—	B	⏭️ Skipped
4	B	B	✅
5	C	C	✅
6	A	B	❌
7	—	B	⏭️ Skipped
8	B	B	✅
9	A	C	❌
10	B	B	✅
11	A	B	❌
12	C	A	❌
13	B	C	❌
14	B	B	✅
15	B	B	✅
16	B	B	✅
17	C	C	✅
18	A	B	❌
19	B	C	❌
20	C	C	✅
21	A	B	❌
22	C	C	✅
23	B	B	✅
24	B	C	❌
25	C	B	❌

🏆 Score: 13 / 23 = 57% — Fair, but several key concepts need revision!

❌ Explanations for Wrong Answers

Q6 - You answered A, Correct: B

Serum Na+ 118, urine Na+ 45, urine osm 520

SIADH has 3 key lab features:

Hyponatremia (low serum Na+)
Inappropriately concentrated urine (urine osm > serum osm, usually > 300)
High urine Na+ (> 20-40 mEq/L) because kidneys are NOT sodium-conserving

Option A (Na+ 148, urine Na+ 8, urine osm 80) = picture of dehydration/volume depletion - high serum Na+, kidneys conserving sodium (low urine Na+), dilute urine. That's the opposite of SIADH.

Q9 - You answered A (Nephrogenic DI), Correct: C (Central DI)

This is the most important DI concept to nail:

Test Result	Diagnosis
Fails to concentrate urine on water deprivation	Confirms DI (not primary polydipsia)
Responds to DDAVP (urine osm rises > 50%)	Central DI - kidneys work fine, just no ADH
Does NOT respond to DDAVP	Nephrogenic DI - kidneys are resistant to ADH

In nephrogenic DI, giving more ADH (DDAVP) does nothing because the problem is kidney resistance, not lack of ADH.

Q11 - You answered A (Bromocriptine), Correct: B (Cabergoline)

Both are dopamine agonists that work for prolactinoma, but:

Cabergoline = preferred (twice weekly dosing, better efficacy, fewer side effects like nausea/vomiting)
Bromocriptine = older, daily dosing, more side effects (but used in pregnancy as more safety data exists)

Exam tip: "Which is preferred?" → Always Cabergoline. "Which is safer in pregnancy?" → Bromocriptine.

Q12 - You answered C (Stimulates somatostatin), Correct: A

Prolactin inhibits fertility by suppressing FSH/LH via inhibition of GnRH pulsatility

High prolactin → suppresses GnRH pulse frequency from the hypothalamus → low LH/FSH → anovulation, amenorrhea, infertility. This is also the mechanism behind lactational amenorrhea (natural contraception during breastfeeding).

Q13 - You answered B (Hyperglycemia), Correct: C (Uncontrolled T1DM)

GH secretion is normally suppressed by hyperglycemia (basis of the OGTT suppression test for acromegaly). However, in uncontrolled Type 1 DM, there is low insulin → portal insulin deficiency → liver produces less IGF-1 → reduced negative feedback → GH rises paradoxically high. This contributes to microvascular complications.

Q18 - You answered A (Stimulates GH), Correct: B

Somatostatin is secreted by the hypothalamus AND by D-cells of the pancreatic islets

Somatostatin inhibits GH (it's also called "growth hormone inhibiting hormone - GHIH"). It also inhibits insulin, glucagon, TSH, and gastric acid. It is secreted by:

Hypothalamus (inhibits GH from pituitary)
Pancreatic D-cells (inhibits insulin and glucagon)
GI tract D-cells (inhibits gastric secretion)

Q19 - You answered B (Nipple stimulation), Correct: C

The question asked what does NOT stimulate oxytocin. Nipple stimulation/suckling absolutely DOES stimulate oxytocin (milk ejection reflex). The answer is C - High serum osmolality, because high osmolality stimulates ADH, not oxytocin. Oxytocin is stimulated by: cervical dilation, suckling, estrogen, and social/emotional stimuli.

Q21 - You answered A (Posterior pituitary), Correct: B (Anterior pituitary)

This is a classic confusion point:

Anterior pituitary = communicates via the hypothalamo-hypophyseal PORTAL system (blood-borne releasing hormones)
Posterior pituitary = communicates via direct nerve axons (hypothalamo-hypophyseal TRACT) - no portal system needed

The portal system is what carries TRH, CRH, GHRH, GnRH, somatostatin, dopamine from median eminence to the anterior pituitary.

Q24 - You answered B (Normal ADH), Correct: C (High ADH)

In nephrogenic DI, the problem is kidney resistance to ADH. The body senses dehydration/high osmolality → hypothalamus responds correctly → secretes HIGH amounts of ADH → but kidneys simply don't respond. So ADH is HIGH, not normal. In central DI, ADH is LOW or absent.

Q25 - You answered C (Adrenal cortex + thyroid), Correct: B (Parathyroid + pancreas)

MEN 1 = "3 P's":

Pituitary (prolactinoma most common)
Parathyroid (hyperplasia → hypercalcemia, most common feature)
Pancreas (gastrinoma/insulinoma)

Gene: MEN1 (menin tumor suppressor on chromosome 11). MEN 2A = medullary thyroid + pheo + parathyroid. MEN 2B = medullary thyroid + pheo + marfanoid + mucosal neuromas.

📌 Key Topics to Revise

Topic	What to Focus On
SIADH labs	Hyponatremia + high urine Na+ + concentrated urine
DI water deprivation test	Central vs nephrogenic response to DDAVP
Prolactinoma treatment	Cabergoline > bromocriptine
Prolactin mechanism	GnRH suppression → low LH/FSH
Somatostatin	Inhibits GH, dual location (hypothalamus + pancreas)
Oxytocin vs ADH stimuli	High osmolality → ADH, not oxytocin
HH axis communication	Portal (anterior) vs direct axons (posterior)
Nephrogenic DI	High ADH, kidneys don't respond
MEN 1	3 P's: Pituitary, Parathyroid, Pancreas

Want me to quiz you again specifically on the 10 topics you got wrong, or do a deeper explanation on any one topic? 💪

Quiz me again on just the topics I struggled with

Here are 15 fresh MCQs targeting exactly the 10 topics you struggled with — 2 questions minimum per weak area!

🎯 Targeted Revision Quiz

🔬 SIADH Labs

Q1. A patient has serum Na+ of 122 mEq/L, serum osmolality of 255 mOsm/kg, urine osmolality of 480 mOsm/kg, and urine Na+ of 55 mEq/L. The patient appears euvolemic. What is the diagnosis?

A) Central diabetes insipidus
B) Primary polydipsia
C) SIADH
D) Addison's disease

Q2. Which single lab finding BEST differentiates SIADH from other causes of hyponatremia like heart failure or cirrhosis?

A) Low serum sodium
B) High urine sodium (> 40 mEq/L) despite hyponatremia
C) Low urine osmolality
D) Low serum osmolality

💧 DI - Water Deprivation Test

Q3. After water deprivation, a patient's urine osmolality is 180 mOsm/kg. After DDAVP administration, urine osmolality rises to 650 mOsm/kg. What is the diagnosis?

A) Primary polydipsia
B) Nephrogenic DI
C) SIADH
D) Central DI

Q4. A patient with nephrogenic DI is given DDAVP. What is the expected urine osmolality response?

A) Rises by > 50%
B) Rises by > 100%
C) Minimal or no change
D) Falls further

💊 Prolactinoma Treatment

Q5. A 32-year-old woman with a microprolactinoma wants to conceive. She is currently on cabergoline. Which statement is CORRECT regarding her management?

A) Cabergoline should be continued throughout pregnancy
B) Cabergoline should ideally be stopped once pregnancy is confirmed; bromocriptine has more safety data in pregnancy
C) Surgery is mandatory before attempting conception
D) Prolactin levels should be checked weekly during pregnancy

Q6. A patient with a macroprolactinoma on cabergoline develops visual field defects. What is the MOST appropriate next step?

A) Increase cabergoline dose
B) Switch to bromocriptine
C) Urgent surgical decompression (transsphenoidal)
D) Add radiotherapy immediately

🔄 Prolactin Mechanism (GnRH suppression)

Q7. A lactating woman has not had a menstrual period for 8 months postpartum. Her pregnancy test is negative. The MOST likely mechanism is:

A) Prolactin directly destroys ovarian follicles
B) Prolactin suppresses GnRH pulsatility → low LH/FSH → anovulation
C) Prolactin stimulates somatostatin which inhibits FSH
D) Prolactin competes with estrogen at uterine receptors

📉 Somatostatin

Q8. Octreotide (a somatostatin analogue) is used to treat acromegaly because it:

A) Blocks GH receptors on target tissues
B) Stimulates dopamine release to inhibit GH
C) Mimics somatostatin to inhibit GH secretion from the pituitary
D) Destroys somatotroph cells directly

Q9. Which of the following is NOT an effect of somatostatin?

A) Inhibition of GH release
B) Inhibition of insulin secretion
C) Stimulation of glucagon secretion
D) Inhibition of TSH release

🧪 Oxytocin vs ADH Stimuli

Q10. A patient in the desert becomes severely dehydrated with a serum osmolality of 310 mOsm/kg. Which hormone is PRIMARILY released in response to this?

A) Oxytocin
B) Cortisol
C) Aldosterone
D) ADH

Q11. All of the following stimulate oxytocin release EXCEPT:

A) Suckling at the breast
B) Cervical stretching during labor
C) Increased serum osmolality
D) Estrogen priming

🔀 HH Axis - Portal vs Direct Axons

Q12. Hypothalamic releasing hormones (TRH, CRH, GHRH, GnRH) reach the anterior pituitary via:

A) Direct axonal projections through the pituitary stalk
B) The hypothalamo-hypophyseal portal blood system
C) Passive diffusion through CSF
D) Systemic circulation via the jugular vein

Q13. A patient suffers a traumatic pituitary stalk transection. Which hormone would be ELEVATED (not decreased) as a result?

A) GH
B) TSH
C) Prolactin
D) ACTH

🫘 Nephrogenic DI - ADH Levels

Q14. What is the EXPECTED serum ADH level in a patient with nephrogenic diabetes insipidus and a serum osmolality of 310 mOsm/kg?

A) Undetectable
B) Low-normal
C) Markedly elevated
D) Equal to a healthy person at the same osmolality

🧬 MEN 1

Q15. A 35-year-old man has a prolactinoma, recurrent kidney stones (due to hypercalcemia), and a gastric ulcer resistant to PPI therapy. Which genetic mutation is most likely responsible?

A) RET proto-oncogene mutation
B) MEN1 gene mutation (menin protein)
C) VHL gene mutation
D) PTEN mutation

📝 Reply with your answers like: 1-C, 2-B, 3-D... and I'll score and explain everything! 🎯

15-B 14-c 13 12 B 11 C 10 D 9 D 8-a 7 c 6 c 4 a 3 b 2 b 1 c

Q5 and Q13 were skipped, so scored out of 13.

📊 Your Scorecard

Q	Topic	Your Answer	Correct	Result
1	SIADH Labs	C	C	✅
2	SIADH Labs	B	B	✅
3	DI - Water Deprivation	B	D	❌
4	DI - DDAVP response	A	C	❌
6	Prolactinoma Treatment	C	C	✅
7	Prolactin Mechanism	C	B	❌
8	Somatostatin	A	C	❌
9	Somatostatin	D	C	❌
10	Oxytocin vs ADH	D	D	✅
11	Oxytocin vs ADH	C	C	✅
12	HH Axis	B	B	✅
14	Nephrogenic DI - ADH	C	C	✅
15	MEN 1	B	B	✅

🏆 Score: 9 / 13 = 69% — Improving! But 4 concepts still need work.

❌ Detailed Explanations for Wrong Answers

Q3 - You answered B (Nephrogenic DI), Correct: D (Central DI)

This is the same concept you missed last round — let's fix it for good.

The rule for the DDAVP test:

Scenario	What happens
Water deprivation → urine stays dilute (< 300 mOsm)	Confirms DI (not primary polydipsia)
Give DDAVP → urine concentrates well (> 50% rise)	Central DI ✅ kidneys work, just no ADH
Give DDAVP → urine stays dilute (< 10% rise)	Nephrogenic DI ✅ kidneys can't respond

In Q3: urine went from 180 → 650 mOsm/kg after DDAVP = huge response = Central DI. In nephrogenic DI, DDAVP does almost nothing because the kidneys are resistant to ADH - giving more ADH via DDAVP changes nothing.

Memory trick: Central DI = the factory (hypothalamus) is broken but the warehouse (kidney) works fine. Give DDAVP = replace the missing hormone = kidneys respond perfectly.

Q4 - You answered A (Rises > 50%), Correct: C (Minimal or no change)

This directly follows from Q3. In nephrogenic DI:

The kidneys have defective V2 receptors or broken aquaporin-2 insertion
It doesn't matter how much ADH or DDAVP you give
The response is minimal or no change in urine osmolality
This is what differentiates it FROM central DI

You answered A — which is actually the correct response for central DI, not nephrogenic. These two are exact opposites.

DI Type	ADH level	DDAVP response
Central	LOW	✅ Good response
Nephrogenic	HIGH	❌ No response

Q7 - You answered C (Somatostatin stimulates somatostatin), Correct: B

Prolactin suppresses GnRH pulsatility → low LH/FSH → anovulation

You picked C (prolactin stimulates somatostatin which inhibits FSH) - this pathway does not exist and is not physiologically relevant.

The correct and direct pathway is:

High Prolactin
      ↓
Suppresses GnRH pulsatility (hypothalamus)
      ↓
Low LH and FSH (anterior pituitary)
      ↓
No follicle development, no ovulation
      ↓
Amenorrhea + Infertility

This is also why hyperprolactinemia presents with secondary amenorrhea and why treating the prolactinoma with cabergoline restores fertility. It is also the mechanism of lactational amenorrhea - a natural (though unreliable) contraceptive effect.

Q8 - You answered A (Blocks GH receptors), Correct: C

Octreotide mimics somatostatin to INHIBIT GH secretion from the pituitary

You answered A - that is actually the mechanism of pegvisomant (a GH receptor antagonist, used as second/third line in acromegaly).

The difference:

Drug	Mechanism	Use
Octreotide / Lanreotide	Somatostatin analogue → inhibits GH secretion from pituitary	First-line medical Rx for acromegaly
Pegvisomant	GH receptor antagonist → blocks GH action at target tissues	Used when octreotide fails
Cabergoline	Dopamine agonist → inhibits GH in some tumors	Useful if prolactin also co-secreted

Q9 - You answered D (Stimulation of glucagon), Correct: C (Stimulation of glucagon is NOT an effect)

Wait - you answered D and the correct answer is C. These are actually the same statement! Let me clarify:

The question asked what is NOT an effect of somatostatin.

Somatostatin inhibits glucagon (it does NOT stimulate it). So the answer is:

C: "Stimulation of glucagon secretion" - this is NOT an effect (somatostatin actually INHIBITS glucagon)

You answered D (Inhibition of TSH release) - somatostatin actually does inhibit TSH, so D IS a real effect of somatostatin, meaning D cannot be the "NOT" answer.

Somatostatin inhibits ALL of these:

✅ GH (anterior pituitary)
✅ TSH (anterior pituitary)
✅ Insulin (pancreatic B-cells)
✅ Glucagon (pancreatic A-cells)
✅ Gastric acid, secretin, CCK (GI tract)

The only thing it does NOT do is stimulate glucagon - that would be the opposite of its effect.

📌 The 4 Concepts to Master Before Your Exam

1. Central vs Nephrogenic DI - DDAVP test

Central = responds to DDAVP (urine concentrates) Nephrogenic = does NOT respond (kidneys resistant)

2. Prolactin → infertility mechanism

Prolactin ↑ → GnRH pulsatility ↓ → LH/FSH ↓ → anovulation (Not via somatostatin - that pathway doesn't exist)

3. Octreotide vs Pegvisomant

Octreotide = inhibits GH secretion (somatostatin analogue) Pegvisomant = blocks GH receptors at target tissues

4. Somatostatin effects

Inhibits everything: GH, TSH, insulin, glucagon, GI secretions Never stimulates glucagon

📈 Your Progress Across Both Rounds

Round	Score
Round 1 (full 23 Qs)	57%
Round 2 (targeted 13 Qs)	69%
Improvement	+12% 📈

Want one final knockout round on just these 4 remaining weak spots to lock them in before your exam? 🎯

This is a shared conversation. Sign in to Orris to start your own chat.